Rhythm Pharmaceuticals, Inc. (RYTM) Discusses FDA Extension of PDUFA Goal Date for Setmelanotide in Hypothalamic Obesity - Slideshow (NASDAQ:RYTM) 2025-12-05

Group 1 - The article does not provide any relevant content regarding company or industry insights [1]